Balanced Pharma Incorporated (BPI) has announced the acquisition of rights to a promising new non-opioid injectable post-surgical pain relief drug, Enduracaine Dental, for the worldwide
The United States Patent & Trademark Office has granted Balanced Pharma, Inc. (BPI) a second patent for its cartridge technology, which enables the long-sought ability
Balanced Pharma, Inc. (BPI) is pleased to announce the appointment of Alex Sadusky to the Advisory Board of Balanced Pharma. Balanced Pharma is a North
More than seven out of 10 patients said they would pay extra if their dentist used a faster, less painful local anesthetic, according to a